These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 19615872

  • 21. Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model.
    Schmidt S, Vieweger A, Obst M, Mueller S, Gross V, Gutberlet M, Steinbrink J, Taubert S, Misselwitz B, Luedemann L, Spuler S.
    Radiology; 2009 Jan; 250(1):87-94. PubMed ID: 19001151
    [Abstract] [Full Text] [Related]

  • 22. Dual effects of exercise in dysferlinopathy.
    Biondi O, Villemeur M, Marchand A, Chretien F, Bourg N, Gherardi RK, Richard I, Authier FJ.
    Am J Pathol; 2013 Jun; 182(6):2298-309. PubMed ID: 23624156
    [Abstract] [Full Text] [Related]

  • 23. Comparative Gene Expression Analysis in the Skeletal Muscles of Dysferlin-deficient SJL/J and A/J Mice.
    Kobayashi K, Izawa T, Kuwamura M, Yamate J.
    J Toxicol Pathol; 2011 Mar; 24(1):49-62. PubMed ID: 22272044
    [Abstract] [Full Text] [Related]

  • 24. Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset.
    Kesari A, Fukuda M, Knoblach S, Bashir R, Nader GA, Rao D, Nagaraju K, Hoffman EP.
    Am J Pathol; 2008 Nov; 173(5):1476-87. PubMed ID: 18832576
    [Abstract] [Full Text] [Related]

  • 25. Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies.
    Cárdenas AM, González-Jamett AM, Cea LA, Bevilacqua JA, Caviedes P.
    Exp Neurol; 2016 Sep; 283(Pt A):246-54. PubMed ID: 27349407
    [Abstract] [Full Text] [Related]

  • 26. Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy.
    Lee YS, Lehar A, Sebald S, Liu M, Swaggart KA, Talbot CC, Pytel P, Barton ER, McNally EM, Lee SJ.
    Hum Mol Genet; 2015 Oct 15; 24(20):5711-9. PubMed ID: 26206886
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
    Leriche-Guérin K, Anderson LV, Wrogemann K, Roy B, Goulet M, Tremblay JP.
    Neuromuscul Disord; 2002 Feb 15; 12(2):167-73. PubMed ID: 11738359
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.
    Chase TH, Cox GA, Burzenski L, Foreman O, Shultz LD.
    Am J Pathol; 2009 Dec 15; 175(6):2299-308. PubMed ID: 19875504
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A/J mice: role of endogenous TLR ligands.
    Uaesoontrachoon K, Cha HJ, Ampong B, Sali A, Vandermeulen J, Wei B, Creeden B, Huynh T, Quinn J, Tatem K, Rayavarapu S, Hoffman EP, Nagaraju K.
    J Pathol; 2013 Oct 15; 231(2):199-209. PubMed ID: 23857504
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.